Stock Events

Stock Events

Biosenic 

€0
0
+€0+11.11% Today

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
0
Avg. Volume
170
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BT1.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap18.49B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with Biosenic's offerings.
Thermo Fisher Scientific
TMO
Mkt Cap184.37B
Thermo Fisher Scientific offers a broad range of biotechnology products, including genomics and proteomics tools, which overlap with Biosenic's market.
Qiagen NV
QGEN
Mkt Cap8.43B
Qiagen is known for sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the diagnostics and research market.
Bio-Rad Laboratories
BIO
Mkt Cap7.54B
Bio-Rad Laboratories manufactures and supplies products and systems used for gene expression, protein purification, and analysis, which are areas Biosenic may also operate in.
Pacific Biosciences of California
PACB
Mkt Cap404.68M
Pacific Biosciences offers long-read sequencing technologies, which can be seen as complementary or competitive to Biosenic's offerings depending on their focus in genomics.
Agenus
AGEN
Mkt Cap152.06M
Agenus is involved in immuno-oncology, a field that may overlap with Biosenic's work if they are involved in developing therapies or diagnostics based on genetic information.
Guardant Health
GH
Mkt Cap10.31B
Guardant Health focuses on liquid biopsies and cancer diagnostics through genomic sequencing, competing in the precision medicine space.
Intellia Therapeutics
NTLA
Mkt Cap1.59B
Intellia Therapeutics is a leading genome editing company, which could be a competitor if Biosenic is involved in therapeutic applications of genomics.
CRISPR Therapeutics
CRSP
Mkt Cap4.92B
CRISPR Therapeutics is focused on developing gene-based medicines, potentially competing with Biosenic if they are involved in therapeutic genomics.

About

BioSenic S.A., a biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France. The company offers arsenic trioxide (ATO) and oral arsenic trioxide (OATO) platforms. It also provides medicinal products, including ArsciMed, an intravenous drug to treat autoimmune diseases. In addition, the company develops 4P004v which is in Phase I clinical trial for veterinary use. BioSenic S.A. is headquartered in Saintes, Belgium.
Show more...
CEO
Mr. Jean-Luc Vandebroek
Employees
7
Country
Belgium
ISIN
BE0974280126

Listings

STU
DE
BT1.STU
F
DE
BT1.F
PA
FR
BIOS.PA
BR
BE
BIOS.BR

0 Comments

Share your thoughts

FAQ

What is Biosenic stock price today?▼
The current price of BT1.STU is €0 EUR — it has increased by +11.11% in the past 24 hours. Watch Biosenic stock price performance more closely on the chart.
What is Biosenic stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Biosenic stocks are traded under the ticker BT1.STU.
Is Biosenic stock price growing?▼
BT1.STU stock has fallen by -0% compared to the previous week, the month change is a -9.09% fall, over the last year Biosenic has showed a +11.11% increase.
How many employees does Biosenic have?▼
As of April 14, 2026, the company has 7 employees.
In which sector is Biosenic located?▼
Biosenic operates in the Health & Wellness sector.
When did Biosenic complete a stock split?▼
Biosenic has not had any recent stock splits.
Where is Biosenic headquartered?▼
Biosenic is headquartered in Saintes, Belgium.